Home › NDC Lookup › RxCUI directory › RxCUI 2054096

Tafenoquine 100 MG Oral Tablet — RxCUI 2054096

Name: Tafenoquine 100 MG Oral Tablet (RxCUI 2054096)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic clinical drug

RxCUI 2054096 Semantic clinical drug · SCD ● Current RxNorm concept 2 FDA products 3 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2054096

Official nameTafenoquine 100 MG Oral Tablet

Concept typeSemantic clinical drug (SCD)

RxNorm statusCurrent RxNorm concept

Also known astafenoquine (as tafenoquine succinate) 100 MG Oral Tablet

FDA products mapped2

Package NDCs mapped3

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Tafenoquine: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist

You're right that both contain tafenoquine, but they're approved for very different purposes. Arakoda (and Kodatef) are for preventing malaria when you're traveling to or living in...
What's the difference between Krintafel and Arakoda — they both seem to be the same drug?
That test checks for something called G6PD deficiency — a genetic condition where your red blood cells lack an enzyme they need to stay healthy under certain stresses. Tafenoquine...
Why do I have to get a blood test before taking this medication?

📖 Read our full Tafenoquine guide →

🕸️ Concept Web — How Tafenoquine 100 MG Oral Tablet Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept Tafenoquine 100 MG Oral Tablet RxCUI 2054096 Semantic clinical drug · SCD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 1

The active substance itself — no strength, form, or brand attached yet.
- Tafenoquine 2054023 IN
Brand names 2

The same medicine's trade names. A brand name alone says nothing about strength or form.
- Arakoda 2054097 BN
- Kodatef 2705370 BN
Dose forms 12

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Tafenoquine Oral Tablet 2054095 SCDF
- Tafenoquine Oral Product 2054093 SCDG
- Tafenoquine Pill 2054094 SCDG
- Tafenoquine Oral Tablet [Arakoda] 2054099 SBDF
- Tafenoquine Oral Tablet [Kodatef] 2705374 SBDF
- Arakoda Oral Product 2054100 SBDG
- Arakoda Pill 2054101 SBDG
- Kodatef Oral Product 2705372 SBDG
- +4 more in this family
Clinical & branded drugs 5

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Tafenoquine 100 MG 2054092 SCDC
- Tafenoquine 100 MG Oral Tablet [Arakoda] 2054102 SBD
- Tafenoquine 100 MG Oral Tablet [Kodatef] 2705375 SBD
- Tafenoquine 100 MG [Arakoda] 2054098 SBDC
- Tafenoquine 100 MG [Kodatef] 2705371 SBDC

Showing up to 8 concepts per family — 16 of 20 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Tafenoquine 100 MG SCDC · 2054092
Tafenoquine Oral Tablet SCDF · 2054095
Tafenoquine Oral Product SCDG · 2054093
Tafenoquine Pill SCDG · 2054094

Brand-Name Concepts

Tafenoquine 100 MG Oral Tablet [Arakoda] SBD · 2054102
Tafenoquine 100 MG Oral Tablet [Kodatef] SBD · 2705375
Tafenoquine 100 MG [Arakoda] SBDC · 2054098
Tafenoquine 100 MG [Kodatef] SBDC · 2705371
Tafenoquine Oral Tablet [Arakoda] SBDF · 2054099
Tafenoquine Oral Tablet [Kodatef] SBDF · 2705374
Arakoda Oral Product SBDG · 2054100
Arakoda Pill SBDG · 2054101
Kodatef Oral Product SBDG · 2705372
Kodatef Pill SBDG · 2705373

📦 FDA Products & Package NDCs

2 products · 3 package NDCs

3 package NDCs map to RxCUI 2054096 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
71475-0257-01	2 BLISTER PACK in 1 CARTON (71475-257-01) / 8 TABLET, FILM...	Arakoda	60 Degrees Pharmaceuticals, INC.	2018-08-20
71475-0257-02	8 TABLET, FILM COATED in 1 BOTTLE (71475-257-02)	Arakoda	60 Degrees Pharmaceuticals, INC.	2018-08-20
71475-0258-03	1 TABLET, FILM COATED in 1 CARTON (71475-258-03)	Kodatef	60 Degrees Pharmaceuticals, INC	2025-02-20

Observed labelers: 60 Degrees Pharmaceuticals, INC. (2) · 60 Degrees Pharmaceuticals, INC (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.